Sujiang Zhang

机构：Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Ruijin Hospital, Tarim University, Shanghai Institute of Hematology · ORCID：0000-0003-1589-9816

发表论文 161 篇 · 总被引 1202 次 · h-index 18

代表论文

• Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial (2024 · Cell stem cell · 被引 79)
• Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties (2023 · Science Translational Medicine · 被引 57)
• A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia vera (2023 · Experimental Hematology and Oncology · 被引 34)
• Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study (2025 · The Lancet Haematology · 被引 7)
• Respiratory microbiota, host immunity, respiratory viral infections and malignant tumors (2025 · Frontiers in Microbiology · 被引 4)
• Therapy related acute myeloid leukemia secondary to CAR-T therapy in refractory/relapsed multiple myeloma patient showing poor prognosis (2025 · Annals of Hematology · 被引 4)